Search Results for: OTAA

The Opioid Treatment Access Act (OTAA) would allow non-opioid-treatment-provider (OTP) physicians with training in addiction to prescribe methadone for opioid use disorder (OUD). This is from Section 4, the highly contested OTAA provision, which the big proprietary OTPs oppose (see the recently launched https://programnotapill.com/) but which some of the smaller ones are … [Read more...] about OTPs facing increasing pressure from supporters of OTAA

Quick summary from AT Forum Confused by all the bills and proposals? That puts you in good company with most of America, except for us nerds who do nothing else. Here’s a quick summary of what’s going on in the methadone (and sometimes, buprenorphine) world, and who’s for what. Regulatory Telemedicine and buprenorphine: The Drug Enforcement Administration is going to … [Read more...] about What’s happening with all the NPRMs and bills?

The rhetoric against methadone has reached stunning levels. When Representative Donald Norcross (D-New Jersey) joined the other congressional sponsors of the Modernizing Opioid Treatment Access Act this month, his press statement referred to the opioid treatment program (OTP) model as a “cartel.” The proposed legislation would, like the OTAA proposed last year (see … [Read more...] about Are OTPs cartels? Congressman Norcross says they are

On December 13, the U.S. Department of Health and Human Services (HHS), through its Substance Abuse and Mental Health Services Administration (SAMHSA), proposed to expand access to treatment for opioid use disorder (OUD). This is very good news for patients, providers, and other stakeholders. Here is the informational statement … [Read more...] about SAMHSA proposal to update methadone regulations: Welcome news for OTPs and patients

The American Association for the Treatment of Opioid Dependence (AATOD) and Opioid Treatment Programs (OTPs) have been at the forefront of trying to reform methadone treatment, always with an eye on patient safety and quality treatment, also while making treatment more accessible. But, as AATOD president Mark Parrino puts it, it’s important to ask “Access to what?” If it’s … [Read more...] about Mythbusting on AATOD and methadone/buprenorphine bills